Dr Michela Noseda leads a team of research at Imperial College London, studying heart failure to develop novel patients stratification and precision medicine approaches. She obtained her MD (Universita' Cattolica del sacro Cuore, Rome) and subsequently a PhD. Michela worked across the US (Albert Einstein College of Medicine and Baylor College of Medicine) and Canada (University of British Columbia) and is now an academic at the National Heart and Lung Institute. She uses genomics and computational approaches to study the cellular and molecular landscape of the human heart and drivers of adverse cardiac remodeling and, develops cardiac disease modelling based on human iPS-derived cells. She co-leads highly interdisciplinary projects and international consortia promoting team-science to accelerate discovery. She is an experienced public engagement advocate communicating how research will advance insights into heart disease that may ultimately alleviate the need for transplantation.
